nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenobarbital—CYP1A1—kidney cancer	0.155	0.653	CbGaD
Phenobarbital—ABCB1—kidney cancer	0.0826	0.347	CbGaD
Phenobarbital—CYP1B1—Erlotinib—kidney cancer	0.023	0.0402	CbGbCtD
Phenobarbital—CYP3A7—Temsirolimus—kidney cancer	0.0215	0.0376	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0215	0.0376	CbGbCtD
Phenobarbital—ABCB11—Paclitaxel—kidney cancer	0.0211	0.0368	CbGbCtD
Phenobarbital—CYP1B1—Paclitaxel—kidney cancer	0.0211	0.0368	CbGbCtD
Phenobarbital—ABCC3—Vincristine—kidney cancer	0.021	0.0367	CbGbCtD
Phenobarbital—ABCC1—Dactinomycin—kidney cancer	0.0209	0.0366	CbGbCtD
Phenobarbital—ABCB11—Vinblastine—kidney cancer	0.0185	0.0322	CbGbCtD
Phenobarbital—ABCB11—Vincristine—kidney cancer	0.0182	0.0317	CbGbCtD
Phenobarbital—CYP3A5—Temsirolimus—kidney cancer	0.0162	0.0282	CbGbCtD
Phenobarbital—ABCC1—Paclitaxel—kidney cancer	0.015	0.0261	CbGbCtD
Phenobarbital—ABCC3—Doxorubicin—kidney cancer	0.0131	0.0229	CbGbCtD
Phenobarbital—ABCC1—Vinblastine—kidney cancer	0.0131	0.0229	CbGbCtD
Phenobarbital—ABCC1—Vincristine—kidney cancer	0.0129	0.0225	CbGbCtD
Phenobarbital—ABCB11—Doxorubicin—kidney cancer	0.0113	0.0198	CbGbCtD
Phenobarbital—CYP1B1—Doxorubicin—kidney cancer	0.0113	0.0198	CbGbCtD
Phenobarbital—ABCC2—Paclitaxel—kidney cancer	0.0111	0.0193	CbGbCtD
Phenobarbital—ABCB1—Temsirolimus—kidney cancer	0.0105	0.0184	CbGbCtD
Phenobarbital—CYP1A1—Erlotinib—kidney cancer	0.0101	0.0176	CbGbCtD
Phenobarbital—ABCC2—Sorafenib—kidney cancer	0.00983	0.0172	CbGbCtD
Phenobarbital—ABCC2—Vinblastine—kidney cancer	0.00971	0.017	CbGbCtD
Phenobarbital—ABCC2—Vincristine—kidney cancer	0.00955	0.0167	CbGbCtD
Phenobarbital—CYP3A4—Everolimus—kidney cancer	0.00933	0.0163	CbGbCtD
Phenobarbital—CYP2C8—Pazopanib—kidney cancer	0.00816	0.0143	CbGbCtD
Phenobarbital—ABCC1—Doxorubicin—kidney cancer	0.00806	0.0141	CbGbCtD
Phenobarbital—ABCC2—Sunitinib—kidney cancer	0.00797	0.0139	CbGbCtD
Phenobarbital—CYP3A7—Paclitaxel—kidney cancer	0.00739	0.0129	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.00739	0.0129	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.00657	0.0115	CbGbCtD
Phenobarbital—CYP3A7—Sorafenib—kidney cancer	0.00657	0.0115	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.00637	0.0111	CbGbCtD
Phenobarbital—CYP3A7—Vincristine—kidney cancer	0.00637	0.0111	CbGbCtD
Phenobarbital—CYP1A2—Pazopanib—kidney cancer	0.00632	0.011	CbGbCtD
Phenobarbital—CYP3A4—Temsirolimus—kidney cancer	0.0063	0.011	CbGbCtD
Phenobarbital—CYP2B6—Sorafenib—kidney cancer	0.00625	0.0109	CbGbCtD
Phenobarbital—CYP3A5—Erlotinib—kidney cancer	0.00606	0.0106	CbGbCtD
Phenobarbital—ABCC2—Doxorubicin—kidney cancer	0.00597	0.0104	CbGbCtD
Phenobarbital—CYP2C9—Capecitabine—kidney cancer	0.00594	0.0104	CbGbCtD
Phenobarbital—CYP2C8—Erlotinib—kidney cancer	0.00582	0.0102	CbGbCtD
Phenobarbital—CYP3A5—Paclitaxel—kidney cancer	0.00555	0.00968	CbGbCtD
Phenobarbital—ABCB1—Pazopanib—kidney cancer	0.00553	0.00965	CbGbCtD
Phenobarbital—CYP2C8—Paclitaxel—kidney cancer	0.00533	0.00931	CbGbCtD
Phenobarbital—CYP3A7—Sunitinib—kidney cancer	0.00532	0.00929	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00532	0.00929	CbGbCtD
Phenobarbital—ABCB1—Dactinomycin—kidney cancer	0.00505	0.00882	CbGbCtD
Phenobarbital—CYP3A5—Sorafenib—kidney cancer	0.00493	0.0086	CbGbCtD
Phenobarbital—CYP3A5—Vincristine—kidney cancer	0.00478	0.00835	CbGbCtD
Phenobarbital—CYP2C8—Sorafenib—kidney cancer	0.00474	0.00827	CbGbCtD
Phenobarbital—CYP1A2—Erlotinib—kidney cancer	0.00451	0.00787	CbGbCtD
Phenobarbital—ABCB1—Gemcitabine—kidney cancer	0.00399	0.00698	CbGbCtD
Phenobarbital—CYP3A5—Sunitinib—kidney cancer	0.00399	0.00697	CbGbCtD
Phenobarbital—CYP2C19—Sorafenib—kidney cancer	0.00397	0.00694	CbGbCtD
Phenobarbital—ABCB1—Erlotinib—kidney cancer	0.00394	0.00689	CbGbCtD
Phenobarbital—CYP2B6—Doxorubicin—kidney cancer	0.00379	0.00663	CbGbCtD
Phenobarbital—CYP2C9—Paclitaxel—kidney cancer	0.00372	0.00649	CbGbCtD
Phenobarbital—CYP1A2—Sorafenib—kidney cancer	0.00367	0.0064	CbGbCtD
Phenobarbital—ABCB1—Paclitaxel—kidney cancer	0.00361	0.0063	CbGbCtD
Phenobarbital—CYP3A4—Pazopanib—kidney cancer	0.00331	0.00578	CbGbCtD
Phenobarbital—CYP2C9—Sorafenib—kidney cancer	0.0033	0.00577	CbGbCtD
Phenobarbital—ABCB1—Sorafenib—kidney cancer	0.00321	0.0056	CbGbCtD
Phenobarbital—ABCB1—Vinblastine—kidney cancer	0.00317	0.00553	CbGbCtD
Phenobarbital—ABCB1—Vincristine—kidney cancer	0.00311	0.00543	CbGbCtD
Phenobarbital—ABCB1—Sunitinib—kidney cancer	0.0026	0.00454	CbGbCtD
Phenobarbital—CYP3A4—Erlotinib—kidney cancer	0.00236	0.00413	CbGbCtD
Phenobarbital—CYP3A4—Paclitaxel—kidney cancer	0.00216	0.00378	CbGbCtD
Phenobarbital—ABCB1—Doxorubicin—kidney cancer	0.00195	0.0034	CbGbCtD
Phenobarbital—CYP3A4—Sorafenib—kidney cancer	0.00192	0.00335	CbGbCtD
Phenobarbital—CYP3A4—Vinblastine—kidney cancer	0.0019	0.00331	CbGbCtD
Phenobarbital—CYP3A4—Vincristine—kidney cancer	0.00186	0.00326	CbGbCtD
Phenobarbital—CYP2C19—urine—kidney cancer	0.00174	0.0526	CbGeAlD
Phenobarbital—CYP3A4—Sunitinib—kidney cancer	0.00156	0.00272	CbGbCtD
Phenobarbital—CYP4A11—renal system—kidney cancer	0.00151	0.0457	CbGeAlD
Phenobarbital—CYP4A11—kidney—kidney cancer	0.00146	0.0442	CbGeAlD
Phenobarbital—CYP4A11—cortex of kidney—kidney cancer	0.00142	0.043	CbGeAlD
Phenobarbital—CYP1A2—urine—kidney cancer	0.00142	0.043	CbGeAlD
Phenobarbital—CYP2C9—urine—kidney cancer	0.00135	0.0408	CbGeAlD
Phenobarbital—CYP2E1—urine—kidney cancer	0.00128	0.0387	CbGeAlD
Phenobarbital—CYP4B1—cardiac atrium—kidney cancer	0.00121	0.0365	CbGeAlD
Phenobarbital—CYP3A4—Doxorubicin—kidney cancer	0.00117	0.00204	CbGbCtD
Phenobarbital—CYP3A4—urine—kidney cancer	0.00103	0.0311	CbGeAlD
Phenobarbital—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.00089	0.0269	CbGeAlD
Phenobarbital—SLCO2A1—nephron tubule—kidney cancer	0.000887	0.0269	CbGeAlD
Phenobarbital—SLCO2A1—renal system—kidney cancer	0.000806	0.0244	CbGeAlD
Phenobarbital—SLCO2A1—kidney—kidney cancer	0.000779	0.0236	CbGeAlD
Phenobarbital—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000762	0.0231	CbGeAlD
Phenobarbital—SLCO2A1—cortex of kidney—kidney cancer	0.000759	0.023	CbGeAlD
Phenobarbital—SLCO2A1—cardiac atrium—kidney cancer	0.000722	0.0219	CbGeAlD
Phenobarbital—CHRNA7—renal system—kidney cancer	0.000661	0.02	CbGeAlD
Phenobarbital—CHRNA7—kidney—kidney cancer	0.000639	0.0194	CbGeAlD
Phenobarbital—ABCC3—renal system—kidney cancer	0.000619	0.0187	CbGeAlD
Phenobarbital—ABCC3—kidney—kidney cancer	0.000598	0.0181	CbGeAlD
Phenobarbital—ABCC2—nephron tubule—kidney cancer	0.000544	0.0165	CbGeAlD
Phenobarbital—CYP1B1—nephron tubule—kidney cancer	0.000533	0.0161	CbGeAlD
Phenobarbital—ABCC2—renal system—kidney cancer	0.000495	0.015	CbGeAlD
Phenobarbital—CYP1B1—renal system—kidney cancer	0.000484	0.0147	CbGeAlD
Phenobarbital—ABCC2—kidney—kidney cancer	0.000478	0.0145	CbGeAlD
Phenobarbital—CYP1B1—kidney—kidney cancer	0.000468	0.0142	CbGeAlD
Phenobarbital—ABCC2—cortex of kidney—kidney cancer	0.000466	0.0141	CbGeAlD
Phenobarbital—CYP1B1—cortex of kidney—kidney cancer	0.000456	0.0138	CbGeAlD
Phenobarbital—CYP1B1—gonad—kidney cancer	0.000434	0.0132	CbGeAlD
Phenobarbital—ABCC1—cortex of kidney—kidney cancer	0.00041	0.0124	CbGeAlD
Phenobarbital—ABCC1—cardiac atrium—kidney cancer	0.00039	0.0118	CbGeAlD
Phenobarbital—CYP2C8—renal system—kidney cancer	0.000371	0.0112	CbGeAlD
Phenobarbital—CYP3A5—nephron tubule—kidney cancer	0.000368	0.0112	CbGeAlD
Phenobarbital—CYP2B6—nephron tubule—kidney cancer	0.000366	0.0111	CbGeAlD
Phenobarbital—CYP2C8—kidney—kidney cancer	0.000359	0.0109	CbGeAlD
Phenobarbital—CYP1A2—renal system—kidney cancer	0.000347	0.0105	CbGeAlD
Phenobarbital—CYP2E1—nephron tubule—kidney cancer	0.000344	0.0104	CbGeAlD
Phenobarbital—CYP1A1—renal system—kidney cancer	0.000342	0.0104	CbGeAlD
Phenobarbital—CYP3A5—renal system—kidney cancer	0.000335	0.0101	CbGeAlD
Phenobarbital—CYP2B6—renal system—kidney cancer	0.000333	0.0101	CbGeAlD
Phenobarbital—CYP1A1—kidney—kidney cancer	0.000331	0.01	CbGeAlD
Phenobarbital—CYP3A5—kidney—kidney cancer	0.000324	0.0098	CbGeAlD
Phenobarbital—CYP2B6—kidney—kidney cancer	0.000322	0.00974	CbGeAlD
Phenobarbital—CYP3A5—cortex of kidney—kidney cancer	0.000315	0.00955	CbGeAlD
Phenobarbital—CYP2E1—renal system—kidney cancer	0.000312	0.00946	CbGeAlD
Phenobarbital—CYP1A1—cardiac atrium—kidney cancer	0.000307	0.00929	CbGeAlD
Phenobarbital—CYP2E1—kidney—kidney cancer	0.000302	0.00914	CbGeAlD
Phenobarbital—CYP2B6—gonad—kidney cancer	0.000298	0.00904	CbGeAlD
Phenobarbital—CYP2E1—cortex of kidney—kidney cancer	0.000294	0.0089	CbGeAlD
Phenobarbital—CYP3A4—renal system—kidney cancer	0.000251	0.00761	CbGeAlD
Phenobarbital—CYP3A4—kidney—kidney cancer	0.000243	0.00736	CbGeAlD
Phenobarbital—Myalgia—Everolimus—kidney cancer	0.00024	0.0027	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Gemcitabine—kidney cancer	0.00024	0.0027	CcSEcCtD
Phenobarbital—Anxiety—Everolimus—kidney cancer	0.000239	0.00269	CcSEcCtD
Phenobarbital—Loss of consciousness—Erlotinib—kidney cancer	0.000239	0.00269	CcSEcCtD
Phenobarbital—Renal failure—Gemcitabine—kidney cancer	0.000238	0.00268	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Paclitaxel—kidney cancer	0.000237	0.00266	CcSEcCtD
Phenobarbital—Erythema—Sunitinib—kidney cancer	0.000235	0.00265	CcSEcCtD
Phenobarbital—Arthralgia—Erlotinib—kidney cancer	0.000232	0.00261	CcSEcCtD
Phenobarbital—Myalgia—Erlotinib—kidney cancer	0.000232	0.00261	CcSEcCtD
Phenobarbital—Anxiety—Erlotinib—kidney cancer	0.000231	0.0026	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Capecitabine—kidney cancer	0.000228	0.00257	CcSEcCtD
Phenobarbital—Hypersensitivity—Temsirolimus—kidney cancer	0.000228	0.00257	CcSEcCtD
Phenobarbital—Hallucination—Vincristine—kidney cancer	0.000228	0.00256	CcSEcCtD
Phenobarbital—Liver injury—Doxorubicin—kidney cancer	0.000227	0.00256	CcSEcCtD
Phenobarbital—Shock—Everolimus—kidney cancer	0.000226	0.00255	CcSEcCtD
Phenobarbital—Dermatitis bullous—Capecitabine—kidney cancer	0.000226	0.00254	CcSEcCtD
Phenobarbital—Angioedema—Sorafenib—kidney cancer	0.000224	0.00252	CcSEcCtD
Phenobarbital—Erythema—Dactinomycin—kidney cancer	0.000223	0.00251	CcSEcCtD
Phenobarbital—Delirium—Doxorubicin—kidney cancer	0.000223	0.00251	CcSEcCtD
Phenobarbital—Lethargy—Capecitabine—kidney cancer	0.00022	0.00248	CcSEcCtD
Phenobarbital—Syncope—Sorafenib—kidney cancer	0.000219	0.00247	CcSEcCtD
Phenobarbital—Extravasation—Doxorubicin—kidney cancer	0.000219	0.00247	CcSEcCtD
Phenobarbital—Shock—Erlotinib—kidney cancer	0.000218	0.00246	CcSEcCtD
Phenobarbital—Angioedema—Sunitinib—kidney cancer	0.000215	0.00242	CcSEcCtD
Phenobarbital—Loss of consciousness—Sorafenib—kidney cancer	0.000215	0.00242	CcSEcCtD
Phenobarbital—Hypotension—Everolimus—kidney cancer	0.000215	0.00242	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Everolimus—kidney cancer	0.00021	0.00236	CcSEcCtD
Phenobarbital—Thinking abnormal—Doxorubicin—kidney cancer	0.000209	0.00236	CcSEcCtD
Phenobarbital—Hypocalcaemia—Doxorubicin—kidney cancer	0.000209	0.00236	CcSEcCtD
Phenobarbital—Myalgia—Sorafenib—kidney cancer	0.000208	0.00235	CcSEcCtD
Phenobarbital—Arthralgia—Sorafenib—kidney cancer	0.000208	0.00235	CcSEcCtD
Phenobarbital—Irritability—Capecitabine—kidney cancer	0.000206	0.00232	CcSEcCtD
Phenobarbital—Erythema multiforme—Gemcitabine—kidney cancer	0.000205	0.00231	CcSEcCtD
Phenobarbital—Somnolence—Everolimus—kidney cancer	0.000205	0.0023	CcSEcCtD
Phenobarbital—Dizziness—Temsirolimus—kidney cancer	0.000205	0.0023	CcSEcCtD
Phenobarbital—Mood swings—Capecitabine—kidney cancer	0.000204	0.0023	CcSEcCtD
Phenobarbital—Ataxia—Capecitabine—kidney cancer	0.000203	0.00228	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000202	0.00228	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.000201	0.00226	CcSEcCtD
Phenobarbital—Arthralgia—Sunitinib—kidney cancer	0.0002	0.00226	CcSEcCtD
Phenobarbital—Myalgia—Sunitinib—kidney cancer	0.0002	0.00226	CcSEcCtD
Phenobarbital—Renal failure—Paclitaxel—kidney cancer	0.000199	0.00224	CcSEcCtD
Phenobarbital—Constipation—Vinblastine—kidney cancer	0.000198	0.00222	CcSEcCtD
Phenobarbital—Pain—Vinblastine—kidney cancer	0.000198	0.00222	CcSEcCtD
Phenobarbital—Pain—Everolimus—kidney cancer	0.000197	0.00222	CcSEcCtD
Phenobarbital—Constipation—Everolimus—kidney cancer	0.000197	0.00222	CcSEcCtD
Phenobarbital—Vomiting—Temsirolimus—kidney cancer	0.000197	0.00222	CcSEcCtD
Phenobarbital—Shock—Sorafenib—kidney cancer	0.000196	0.00221	CcSEcCtD
Phenobarbital—ABCB1—nephron tubule—kidney cancer	0.000196	0.00593	CbGeAlD
Phenobarbital—Rash—Temsirolimus—kidney cancer	0.000195	0.0022	CcSEcCtD
Phenobarbital—Dermatitis—Temsirolimus—kidney cancer	0.000195	0.00219	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.000194	0.00219	CcSEcCtD
Phenobarbital—Headache—Temsirolimus—kidney cancer	0.000194	0.00218	CcSEcCtD
Phenobarbital—Dizziness—Pazopanib—kidney cancer	0.000193	0.00217	CcSEcCtD
Phenobarbital—Hepatocellular injury—Doxorubicin—kidney cancer	0.000191	0.00216	CcSEcCtD
Phenobarbital—Feeling abnormal—Vinblastine—kidney cancer	0.00019	0.00214	CcSEcCtD
Phenobarbital—Injection site reaction—Doxorubicin—kidney cancer	0.00019	0.00214	CcSEcCtD
Phenobarbital—Pain—Erlotinib—kidney cancer	0.00019	0.00214	CcSEcCtD
Phenobarbital—Constipation—Erlotinib—kidney cancer	0.00019	0.00214	CcSEcCtD
Phenobarbital—Myalgia—Dactinomycin—kidney cancer	0.00019	0.00214	CcSEcCtD
Phenobarbital—Feeling abnormal—Everolimus—kidney cancer	0.00019	0.00214	CcSEcCtD
Phenobarbital—Shock—Sunitinib—kidney cancer	0.000189	0.00213	CcSEcCtD
Phenobarbital—Erythema—Gemcitabine—kidney cancer	0.000189	0.00213	CcSEcCtD
Phenobarbital—Asthma—Capecitabine—kidney cancer	0.000186	0.0021	CcSEcCtD
Phenobarbital—Vomiting—Pazopanib—kidney cancer	0.000185	0.00209	CcSEcCtD
Phenobarbital—Bradycardia—Paclitaxel—kidney cancer	0.000185	0.00208	CcSEcCtD
Phenobarbital—Rash—Pazopanib—kidney cancer	0.000184	0.00207	CcSEcCtD
Phenobarbital—Nausea—Temsirolimus—kidney cancer	0.000184	0.00207	CcSEcCtD
Phenobarbital—Dermatitis—Pazopanib—kidney cancer	0.000184	0.00207	CcSEcCtD
Phenobarbital—Agitation—Vincristine—kidney cancer	0.000183	0.00206	CcSEcCtD
Phenobarbital—Headache—Pazopanib—kidney cancer	0.000183	0.00206	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000182	0.00205	CcSEcCtD
Phenobarbital—Body temperature increased—Everolimus—kidney cancer	0.000182	0.00205	CcSEcCtD
Phenobarbital—Vertigo—Vincristine—kidney cancer	0.000179	0.00202	CcSEcCtD
Phenobarbital—ABCB1—renal system—kidney cancer	0.000178	0.00539	CbGeAlD
Phenobarbital—Body temperature increased—Erlotinib—kidney cancer	0.000175	0.00198	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000175	0.00197	CcSEcCtD
Phenobarbital—Coma—Doxorubicin—kidney cancer	0.000175	0.00197	CcSEcCtD
Phenobarbital—Nausea—Pazopanib—kidney cancer	0.000173	0.00195	CcSEcCtD
Phenobarbital—ABCB1—kidney—kidney cancer	0.000172	0.00521	CbGeAlD
Phenobarbital—Erythema multiforme—Paclitaxel—kidney cancer	0.000172	0.00194	CcSEcCtD
Phenobarbital—Constipation—Sorafenib—kidney cancer	0.000171	0.00192	CcSEcCtD
Phenobarbital—Pain—Sorafenib—kidney cancer	0.000171	0.00192	CcSEcCtD
Phenobarbital—Hypersensitivity—Vinblastine—kidney cancer	0.00017	0.00192	CcSEcCtD
Phenobarbital—Myalgia—Vincristine—kidney cancer	0.00017	0.00191	CcSEcCtD
Phenobarbital—Hypersensitivity—Everolimus—kidney cancer	0.00017	0.00191	CcSEcCtD
Phenobarbital—ABCB1—cortex of kidney—kidney cancer	0.000167	0.00507	CbGeAlD
Phenobarbital—Mental disability—Doxorubicin—kidney cancer	0.000166	0.00187	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000166	0.00187	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000165	0.00186	CcSEcCtD
Phenobarbital—Constipation—Sunitinib—kidney cancer	0.000164	0.00185	CcSEcCtD
Phenobarbital—Pain—Sunitinib—kidney cancer	0.000164	0.00185	CcSEcCtD
Phenobarbital—Renal failure—Capecitabine—kidney cancer	0.000163	0.00184	CcSEcCtD
Phenobarbital—Arthralgia—Gemcitabine—kidney cancer	0.000161	0.00181	CcSEcCtD
Phenobarbital—Myalgia—Gemcitabine—kidney cancer	0.000161	0.00181	CcSEcCtD
Phenobarbital—ABCB1—gonad—kidney cancer	0.000159	0.00483	CbGeAlD
Phenobarbital—Urticaria—Sorafenib—kidney cancer	0.000159	0.00179	CcSEcCtD
Phenobarbital—Erythema—Paclitaxel—kidney cancer	0.000158	0.00178	CcSEcCtD
Phenobarbital—Body temperature increased—Sorafenib—kidney cancer	0.000158	0.00178	CcSEcCtD
Phenobarbital—Pain—Dactinomycin—kidney cancer	0.000156	0.00175	CcSEcCtD
Phenobarbital—Tension—Paclitaxel—kidney cancer	0.000155	0.00175	CcSEcCtD
Phenobarbital—Nervousness—Paclitaxel—kidney cancer	0.000154	0.00173	CcSEcCtD
Phenobarbital—Dizziness—Vinblastine—kidney cancer	0.000153	0.00172	CcSEcCtD
Phenobarbital—Dizziness—Everolimus—kidney cancer	0.000152	0.00171	CcSEcCtD
Phenobarbital—Body temperature increased—Sunitinib—kidney cancer	0.000152	0.00171	CcSEcCtD
Phenobarbital—Hypotension—Vincristine—kidney cancer	0.000152	0.00171	CcSEcCtD
Phenobarbital—Bradycardia—Capecitabine—kidney cancer	0.000152	0.00171	CcSEcCtD
Phenobarbital—Feeling abnormal—Dactinomycin—kidney cancer	0.00015	0.00169	CcSEcCtD
Phenobarbital—Hepatitis—Capecitabine—kidney cancer	0.000149	0.00168	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000148	0.00167	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000147	0.00166	CcSEcCtD
Phenobarbital—Hypersensitivity—Sorafenib—kidney cancer	0.000147	0.00166	CcSEcCtD
Phenobarbital—Vomiting—Vinblastine—kidney cancer	0.000147	0.00165	CcSEcCtD
Phenobarbital—Dizziness—Erlotinib—kidney cancer	0.000147	0.00165	CcSEcCtD
Phenobarbital—Vomiting—Everolimus—kidney cancer	0.000146	0.00165	CcSEcCtD
Phenobarbital—Dermatitis bullous—Doxorubicin—kidney cancer	0.000145	0.00164	CcSEcCtD
Phenobarbital—Agitation—Paclitaxel—kidney cancer	0.000145	0.00164	CcSEcCtD
Phenobarbital—Rash—Everolimus—kidney cancer	0.000145	0.00163	CcSEcCtD
Phenobarbital—Dermatitis—Everolimus—kidney cancer	0.000145	0.00163	CcSEcCtD
Phenobarbital—Headache—Vinblastine—kidney cancer	0.000145	0.00163	CcSEcCtD
Phenobarbital—Angioedema—Paclitaxel—kidney cancer	0.000145	0.00163	CcSEcCtD
Phenobarbital—Headache—Everolimus—kidney cancer	0.000144	0.00162	CcSEcCtD
Phenobarbital—Hypotension—Gemcitabine—kidney cancer	0.000144	0.00162	CcSEcCtD
Phenobarbital—Body temperature increased—Dactinomycin—kidney cancer	0.000144	0.00162	CcSEcCtD
Phenobarbital—Vertigo—Paclitaxel—kidney cancer	0.000142	0.0016	CcSEcCtD
Phenobarbital—Syncope—Paclitaxel—kidney cancer	0.000142	0.0016	CcSEcCtD
Phenobarbital—Lethargy—Doxorubicin—kidney cancer	0.000142	0.0016	CcSEcCtD
Phenobarbital—Hypersensitivity—Sunitinib—kidney cancer	0.000142	0.00159	CcSEcCtD
Phenobarbital—Vomiting—Erlotinib—kidney cancer	0.000141	0.00159	CcSEcCtD
Phenobarbital—Erythema multiforme—Capecitabine—kidney cancer	0.000141	0.00159	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00014	0.00158	CcSEcCtD
Phenobarbital—Rash—Erlotinib—kidney cancer	0.00014	0.00158	CcSEcCtD
Phenobarbital—Dermatitis—Erlotinib—kidney cancer	0.00014	0.00158	CcSEcCtD
Phenobarbital—Headache—Erlotinib—kidney cancer	0.000139	0.00157	CcSEcCtD
Phenobarbital—Loss of consciousness—Paclitaxel—kidney cancer	0.000139	0.00157	CcSEcCtD
Phenobarbital—Pain—Vincristine—kidney cancer	0.000139	0.00157	CcSEcCtD
Phenobarbital—Constipation—Vincristine—kidney cancer	0.000139	0.00157	CcSEcCtD
Phenobarbital—Nausea—Vinblastine—kidney cancer	0.000137	0.00155	CcSEcCtD
Phenobarbital—Somnolence—Gemcitabine—kidney cancer	0.000137	0.00154	CcSEcCtD
Phenobarbital—Affect lability—Doxorubicin—kidney cancer	0.000137	0.00154	CcSEcCtD
Phenobarbital—Nausea—Everolimus—kidney cancer	0.000137	0.00154	CcSEcCtD
Phenobarbital—Arthralgia—Paclitaxel—kidney cancer	0.000135	0.00152	CcSEcCtD
Phenobarbital—Myalgia—Paclitaxel—kidney cancer	0.000135	0.00152	CcSEcCtD
Phenobarbital—Anxiety—Paclitaxel—kidney cancer	0.000134	0.00151	CcSEcCtD
Phenobarbital—Hypersensitivity—Dactinomycin—kidney cancer	0.000134	0.00151	CcSEcCtD
Phenobarbital—Dizziness—Sorafenib—kidney cancer	0.000132	0.00149	CcSEcCtD
Phenobarbital—Constipation—Gemcitabine—kidney cancer	0.000132	0.00149	CcSEcCtD
Phenobarbital—Pain—Gemcitabine—kidney cancer	0.000132	0.00149	CcSEcCtD
Phenobarbital—Nausea—Erlotinib—kidney cancer	0.000132	0.00149	CcSEcCtD
Phenobarbital—Mood swings—Doxorubicin—kidney cancer	0.000132	0.00148	CcSEcCtD
Phenobarbital—Ataxia—Doxorubicin—kidney cancer	0.000131	0.00147	CcSEcCtD
Phenobarbital—Confusional state—Paclitaxel—kidney cancer	0.00013	0.00147	CcSEcCtD
Phenobarbital—Erythema—Capecitabine—kidney cancer	0.00013	0.00146	CcSEcCtD
Phenobarbital—Body temperature increased—Vincristine—kidney cancer	0.000128	0.00145	CcSEcCtD
Phenobarbital—Dizziness—Sunitinib—kidney cancer	0.000127	0.00143	CcSEcCtD
Phenobarbital—Feeling abnormal—Gemcitabine—kidney cancer	0.000127	0.00143	CcSEcCtD
Phenobarbital—Shock—Paclitaxel—kidney cancer	0.000127	0.00143	CcSEcCtD
Phenobarbital—Vomiting—Sorafenib—kidney cancer	0.000127	0.00143	CcSEcCtD
Phenobarbital—Rash—Sorafenib—kidney cancer	0.000126	0.00142	CcSEcCtD
Phenobarbital—Dermatitis—Sorafenib—kidney cancer	0.000126	0.00142	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000125	0.00141	CcSEcCtD
Phenobarbital—Headache—Sorafenib—kidney cancer	0.000125	0.00141	CcSEcCtD
Phenobarbital—Vomiting—Sunitinib—kidney cancer	0.000122	0.00138	CcSEcCtD
Phenobarbital—Body temperature increased—Gemcitabine—kidney cancer	0.000122	0.00137	CcSEcCtD
Phenobarbital—Rash—Sunitinib—kidney cancer	0.000121	0.00136	CcSEcCtD
Phenobarbital—Dermatitis—Sunitinib—kidney cancer	0.000121	0.00136	CcSEcCtD
Phenobarbital—Hypotension—Paclitaxel—kidney cancer	0.000121	0.00136	CcSEcCtD
Phenobarbital—Headache—Sunitinib—kidney cancer	0.00012	0.00136	CcSEcCtD
Phenobarbital—Asthma—Doxorubicin—kidney cancer	0.00012	0.00135	CcSEcCtD
Phenobarbital—Hypersensitivity—Vincristine—kidney cancer	0.00012	0.00135	CcSEcCtD
Phenobarbital—Nausea—Sorafenib—kidney cancer	0.000119	0.00134	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000118	0.00132	CcSEcCtD
Phenobarbital—Vertigo—Capecitabine—kidney cancer	0.000117	0.00131	CcSEcCtD
Phenobarbital—Syncope—Capecitabine—kidney cancer	0.000116	0.00131	CcSEcCtD
Phenobarbital—Vomiting—Dactinomycin—kidney cancer	0.000116	0.0013	CcSEcCtD
Phenobarbital—Somnolence—Paclitaxel—kidney cancer	0.000115	0.00129	CcSEcCtD
Phenobarbital—Rash—Dactinomycin—kidney cancer	0.000115	0.00129	CcSEcCtD
Phenobarbital—Nausea—Sunitinib—kidney cancer	0.000114	0.00129	CcSEcCtD
Phenobarbital—Loss of consciousness—Capecitabine—kidney cancer	0.000114	0.00129	CcSEcCtD
Phenobarbital—Arthralgia—Capecitabine—kidney cancer	0.000111	0.00124	CcSEcCtD
Phenobarbital—Myalgia—Capecitabine—kidney cancer	0.000111	0.00124	CcSEcCtD
Phenobarbital—Pain—Paclitaxel—kidney cancer	0.00011	0.00124	CcSEcCtD
Phenobarbital—Constipation—Paclitaxel—kidney cancer	0.00011	0.00124	CcSEcCtD
Phenobarbital—Anxiety—Capecitabine—kidney cancer	0.00011	0.00124	CcSEcCtD
Phenobarbital—Nausea—Dactinomycin—kidney cancer	0.000108	0.00122	CcSEcCtD
Phenobarbital—Dizziness—Vincristine—kidney cancer	0.000107	0.00121	CcSEcCtD
Phenobarbital—Drowsiness—Doxorubicin—kidney cancer	0.000107	0.00121	CcSEcCtD
Phenobarbital—Confusional state—Capecitabine—kidney cancer	0.000107	0.0012	CcSEcCtD
Phenobarbital—Feeling abnormal—Paclitaxel—kidney cancer	0.000106	0.0012	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000106	0.0012	CcSEcCtD
Phenobarbital—Renal failure—Doxorubicin—kidney cancer	0.000105	0.00119	CcSEcCtD
Phenobarbital—Shock—Capecitabine—kidney cancer	0.000104	0.00117	CcSEcCtD
Phenobarbital—Vomiting—Vincristine—kidney cancer	0.000103	0.00116	CcSEcCtD
Phenobarbital—Urticaria—Paclitaxel—kidney cancer	0.000103	0.00116	CcSEcCtD
Phenobarbital—Rash—Vincristine—kidney cancer	0.000102	0.00115	CcSEcCtD
Phenobarbital—Dermatitis—Vincristine—kidney cancer	0.000102	0.00115	CcSEcCtD
Phenobarbital—Body temperature increased—Paclitaxel—kidney cancer	0.000102	0.00115	CcSEcCtD
Phenobarbital—Headache—Vincristine—kidney cancer	0.000102	0.00115	CcSEcCtD
Phenobarbital—Hypotension—Capecitabine—kidney cancer	9.9e-05	0.00112	CcSEcCtD
Phenobarbital—Vomiting—Gemcitabine—kidney cancer	9.8e-05	0.0011	CcSEcCtD
Phenobarbital—Bradycardia—Doxorubicin—kidney cancer	9.79e-05	0.0011	CcSEcCtD
Phenobarbital—Rash—Gemcitabine—kidney cancer	9.72e-05	0.0011	CcSEcCtD
Phenobarbital—Dermatitis—Gemcitabine—kidney cancer	9.71e-05	0.00109	CcSEcCtD
Phenobarbital—Headache—Gemcitabine—kidney cancer	9.66e-05	0.00109	CcSEcCtD
Phenobarbital—Nausea—Vincristine—kidney cancer	9.65e-05	0.00109	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Capecitabine—kidney cancer	9.65e-05	0.00109	CcSEcCtD
Phenobarbital—Hepatitis—Doxorubicin—kidney cancer	9.61e-05	0.00108	CcSEcCtD
Phenobarbital—Hypersensitivity—Paclitaxel—kidney cancer	9.51e-05	0.00107	CcSEcCtD
Phenobarbital—Nausea—Gemcitabine—kidney cancer	9.16e-05	0.00103	CcSEcCtD
Phenobarbital—Erythema multiforme—Doxorubicin—kidney cancer	9.09e-05	0.00102	CcSEcCtD
Phenobarbital—Constipation—Capecitabine—kidney cancer	9.06e-05	0.00102	CcSEcCtD
Phenobarbital—Pain—Capecitabine—kidney cancer	9.06e-05	0.00102	CcSEcCtD
Phenobarbital—Feeling abnormal—Capecitabine—kidney cancer	8.73e-05	0.000983	CcSEcCtD
Phenobarbital—Dizziness—Paclitaxel—kidney cancer	8.54e-05	0.000962	CcSEcCtD
Phenobarbital—Urticaria—Capecitabine—kidney cancer	8.42e-05	0.000948	CcSEcCtD
Phenobarbital—Body temperature increased—Capecitabine—kidney cancer	8.38e-05	0.000943	CcSEcCtD
Phenobarbital—Erythema—Doxorubicin—kidney cancer	8.37e-05	0.000943	CcSEcCtD
Phenobarbital—Tension—Doxorubicin—kidney cancer	8.21e-05	0.000925	CcSEcCtD
Phenobarbital—Vomiting—Paclitaxel—kidney cancer	8.21e-05	0.000925	CcSEcCtD
Phenobarbital—Rash—Paclitaxel—kidney cancer	8.14e-05	0.000917	CcSEcCtD
Phenobarbital—Dermatitis—Paclitaxel—kidney cancer	8.13e-05	0.000916	CcSEcCtD
Phenobarbital—Nervousness—Doxorubicin—kidney cancer	8.13e-05	0.000915	CcSEcCtD
Phenobarbital—Headache—Paclitaxel—kidney cancer	8.09e-05	0.000911	CcSEcCtD
Phenobarbital—Hypersensitivity—Capecitabine—kidney cancer	7.81e-05	0.000879	CcSEcCtD
Phenobarbital—Agitation—Doxorubicin—kidney cancer	7.69e-05	0.000866	CcSEcCtD
Phenobarbital—Nausea—Paclitaxel—kidney cancer	7.67e-05	0.000864	CcSEcCtD
Phenobarbital—Vertigo—Doxorubicin—kidney cancer	7.52e-05	0.000847	CcSEcCtD
Phenobarbital—Syncope—Doxorubicin—kidney cancer	7.5e-05	0.000845	CcSEcCtD
Phenobarbital—Loss of consciousness—Doxorubicin—kidney cancer	7.35e-05	0.000828	CcSEcCtD
Phenobarbital—Arthralgia—Doxorubicin—kidney cancer	7.12e-05	0.000802	CcSEcCtD
Phenobarbital—Myalgia—Doxorubicin—kidney cancer	7.12e-05	0.000802	CcSEcCtD
Phenobarbital—Anxiety—Doxorubicin—kidney cancer	7.1e-05	0.0008	CcSEcCtD
Phenobarbital—Dizziness—Capecitabine—kidney cancer	7.01e-05	0.000789	CcSEcCtD
Phenobarbital—Confusional state—Doxorubicin—kidney cancer	6.89e-05	0.000776	CcSEcCtD
Phenobarbital—Vomiting—Capecitabine—kidney cancer	6.74e-05	0.000759	CcSEcCtD
Phenobarbital—Shock—Doxorubicin—kidney cancer	6.72e-05	0.000757	CcSEcCtD
Phenobarbital—Rash—Capecitabine—kidney cancer	6.68e-05	0.000752	CcSEcCtD
Phenobarbital—Dermatitis—Capecitabine—kidney cancer	6.67e-05	0.000752	CcSEcCtD
Phenobarbital—Headache—Capecitabine—kidney cancer	6.64e-05	0.000748	CcSEcCtD
Phenobarbital—Hypotension—Doxorubicin—kidney cancer	6.38e-05	0.000719	CcSEcCtD
Phenobarbital—Nausea—Capecitabine—kidney cancer	6.29e-05	0.000709	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.22e-05	0.000701	CcSEcCtD
Phenobarbital—Somnolence—Doxorubicin—kidney cancer	6.07e-05	0.000684	CcSEcCtD
Phenobarbital—Pain—Doxorubicin—kidney cancer	5.84e-05	0.000658	CcSEcCtD
Phenobarbital—Constipation—Doxorubicin—kidney cancer	5.84e-05	0.000658	CcSEcCtD
Phenobarbital—Feeling abnormal—Doxorubicin—kidney cancer	5.63e-05	0.000634	CcSEcCtD
Phenobarbital—Urticaria—Doxorubicin—kidney cancer	5.43e-05	0.000611	CcSEcCtD
Phenobarbital—Body temperature increased—Doxorubicin—kidney cancer	5.4e-05	0.000608	CcSEcCtD
Phenobarbital—Hypersensitivity—Doxorubicin—kidney cancer	5.03e-05	0.000567	CcSEcCtD
Phenobarbital—Dizziness—Doxorubicin—kidney cancer	4.52e-05	0.000509	CcSEcCtD
Phenobarbital—Vomiting—Doxorubicin—kidney cancer	4.34e-05	0.000489	CcSEcCtD
Phenobarbital—Rash—Doxorubicin—kidney cancer	4.31e-05	0.000485	CcSEcCtD
Phenobarbital—Dermatitis—Doxorubicin—kidney cancer	4.3e-05	0.000485	CcSEcCtD
Phenobarbital—Headache—Doxorubicin—kidney cancer	4.28e-05	0.000482	CcSEcCtD
Phenobarbital—Nausea—Doxorubicin—kidney cancer	4.06e-05	0.000457	CcSEcCtD
Phenobarbital—CYP3A5—Metabolism—SCARB1—kidney cancer	5.67e-06	8.37e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—GSTT1—kidney cancer	5.66e-06	8.36e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—ACHE—kidney cancer	5.66e-06	8.36e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PSMD7—kidney cancer	5.63e-06	8.32e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PTGS1—kidney cancer	5.62e-06	8.3e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PTGS1—kidney cancer	5.61e-06	8.29e-05	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—POMC—kidney cancer	5.61e-06	8.29e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—APRT—kidney cancer	5.57e-06	8.23e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—FH—kidney cancer	5.57e-06	8.23e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—CYP1A1—kidney cancer	5.55e-06	8.19e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PSMD7—kidney cancer	5.51e-06	8.14e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PSMD7—kidney cancer	5.5e-06	8.13e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—CRABP1—kidney cancer	5.46e-06	8.07e-05	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—POMC—kidney cancer	5.46e-06	8.06e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—ABCB1—kidney cancer	5.43e-06	8.03e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	5.37e-06	7.93e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—APC—kidney cancer	5.36e-06	7.92e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—KIT—kidney cancer	5.36e-06	7.92e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—SCARB1—kidney cancer	5.35e-06	7.91e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—BCHE—kidney cancer	5.34e-06	7.88e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—CRABP1—kidney cancer	5.33e-06	7.87e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PTGS1—kidney cancer	5.3e-06	7.83e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—GSTM1—kidney cancer	5.28e-06	7.79e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—SLC5A5—kidney cancer	5.27e-06	7.79e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—GSTP1—kidney cancer	5.26e-06	7.77e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.24e-06	7.74e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GPC3—kidney cancer	5.24e-06	7.74e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—BCHE—kidney cancer	5.23e-06	7.72e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—BCHE—kidney cancer	5.22e-06	7.7e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PSMD7—kidney cancer	5.2e-06	7.68e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	5.19e-06	7.67e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—GSTT1—kidney cancer	5.19e-06	7.66e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—ACHE—kidney cancer	5.19e-06	7.66e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—SLC5A5—kidney cancer	5.16e-06	7.63e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—SLC5A5—kidney cancer	5.15e-06	7.61e-05	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—PTGS2—kidney cancer	5.12e-06	7.56e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CA2—kidney cancer	5.09e-06	7.53e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—SLC2A1—kidney cancer	5.09e-06	7.52e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—ITPR2—kidney cancer	5.08e-06	7.5e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—BRAF—kidney cancer	5.04e-06	7.45e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CA9—kidney cancer	5e-06	7.39e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—CYP1A1—kidney cancer	5e-06	7.39e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—SLC2A1—kidney cancer	4.99e-06	7.37e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—ABCB1—kidney cancer	4.98e-06	7.36e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—CRABP1—kidney cancer	4.98e-06	7.35e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—SLC2A1—kidney cancer	4.98e-06	7.35e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ALAD—kidney cancer	4.96e-06	7.33e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—ITPR2—kidney cancer	4.95e-06	7.32e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—BCHE—kidney cancer	4.93e-06	7.28e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—SCARB1—kidney cancer	4.91e-06	7.25e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.89e-06	7.22e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—SLC5A5—kidney cancer	4.87e-06	7.19e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PTGS1—kidney cancer	4.86e-06	7.18e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ST3GAL2—kidney cancer	4.85e-06	7.16e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—GSTM1—kidney cancer	4.84e-06	7.14e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PSMD7—kidney cancer	4.76e-06	7.04e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ALDH1A1—kidney cancer	4.74e-06	7e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.71e-06	6.96e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—SLC2A1—kidney cancer	4.7e-06	6.94e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.68e-06	6.91e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—ACHE—kidney cancer	4.63e-06	6.84e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—GSTT1—kidney cancer	4.63e-06	6.84e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—ITPR2—kidney cancer	4.63e-06	6.84e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—CYP1A1—kidney cancer	4.58e-06	6.77e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.56e-06	6.74e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.56e-06	6.73e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PGK1—kidney cancer	4.54e-06	6.71e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—SLC5A3—kidney cancer	4.54e-06	6.71e-05	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—PTGS2—kidney cancer	4.54e-06	6.71e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—GSTT1—kidney cancer	4.52e-06	6.67e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—ACHE—kidney cancer	4.52e-06	6.67e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—BCHE—kidney cancer	4.52e-06	6.67e-05	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—PTGS2—kidney cancer	4.47e-06	6.61e-05	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—PTEN—kidney cancer	4.46e-06	6.59e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—SLC5A5—kidney cancer	4.46e-06	6.59e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—LDHB—kidney cancer	4.45e-06	6.58e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—SCARB1—kidney cancer	4.38e-06	6.47e-05	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—PTGS2—kidney cancer	4.35e-06	6.43e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PTGS1—kidney cancer	4.34e-06	6.41e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—SLC2A1—kidney cancer	4.31e-06	6.37e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—SCARB1—kidney cancer	4.28e-06	6.32e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—POMC—kidney cancer	4.27e-06	6.32e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.27e-06	6.3e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CRABP1—kidney cancer	4.25e-06	6.28e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PSMD7—kidney cancer	4.25e-06	6.28e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—GSTP1—kidney cancer	4.25e-06	6.27e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PTGS1—kidney cancer	4.23e-06	6.25e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—ACHE—kidney cancer	4.22e-06	6.23e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—GSTT1—kidney cancer	4.22e-06	6.23e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—RAF1—kidney cancer	4.21e-06	6.22e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.18e-06	6.18e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—ERBB2—kidney cancer	4.16e-06	6.15e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—GSTP1—kidney cancer	4.16e-06	6.14e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PSMD7—kidney cancer	4.15e-06	6.13e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—GSTP1—kidney cancer	4.15e-06	6.13e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—POMC—kidney cancer	4.13e-06	6.11e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—MTOR—kidney cancer	4.11e-06	6.07e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—CD4—kidney cancer	4.1e-06	6.06e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—PTGS2—kidney cancer	4.07e-06	6.02e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—BCHE—kidney cancer	4.03e-06	5.96e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—ABCB1—kidney cancer	4.02e-06	5.94e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—SCARB1—kidney cancer	3.99e-06	5.9e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—SLC5A5—kidney cancer	3.98e-06	5.88e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.98e-06	5.88e-05	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—PTEN—kidney cancer	3.96e-06	5.85e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—ITPR2—kidney cancer	3.95e-06	5.84e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PTGS1—kidney cancer	3.95e-06	5.84e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—ABCB1—kidney cancer	3.94e-06	5.82e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—BCHE—kidney cancer	3.94e-06	5.81e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—ABCB1—kidney cancer	3.93e-06	5.8e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—GSTP1—kidney cancer	3.92e-06	5.79e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—GSTM1—kidney cancer	3.9e-06	5.76e-05	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—PTEN—kidney cancer	3.9e-06	5.76e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—SLC5A5—kidney cancer	3.89e-06	5.74e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PSMD7—kidney cancer	3.88e-06	5.73e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CA9—kidney cancer	3.86e-06	5.7e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—CDKN1B—kidney cancer	3.86e-06	5.7e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—SLC2A1—kidney cancer	3.85e-06	5.68e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—GSTM1—kidney cancer	3.82e-06	5.65e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—GSTM1—kidney cancer	3.81e-06	5.63e-05	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—PTEN—kidney cancer	3.8e-06	5.61e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—SLC2A1—kidney cancer	3.75e-06	5.55e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.73e-06	5.51e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—POMC—kidney cancer	3.73e-06	5.51e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—ABCB1—kidney cancer	3.71e-06	5.48e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—CYP1A1—kidney cancer	3.7e-06	5.46e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—BCHE—kidney cancer	3.68e-06	5.43e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.65e-06	5.39e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.65e-06	5.39e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—CTNNB1—kidney cancer	3.64e-06	5.38e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—SLC5A5—kidney cancer	3.63e-06	5.36e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—CYP1A1—kidney cancer	3.62e-06	5.35e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—CYP1A1—kidney cancer	3.61e-06	5.34e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—ACHE—kidney cancer	3.61e-06	5.33e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—GSTT1—kidney cancer	3.61e-06	5.33e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—GSTM1—kidney cancer	3.6e-06	5.32e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—GSTP1—kidney cancer	3.59e-06	5.31e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.58e-06	5.29e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—PTEN—kidney cancer	3.55e-06	5.25e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—SLC2A1—kidney cancer	3.51e-06	5.18e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—POMC—kidney cancer	3.42e-06	5.05e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—SCARB1—kidney cancer	3.41e-06	5.04e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PTGS2—kidney cancer	3.41e-06	5.04e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.4e-06	5.03e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—ABCB1—kidney cancer	3.4e-06	5.03e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PTGS1—kidney cancer	3.38e-06	4.99e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PSMD7—kidney cancer	3.31e-06	4.9e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—GSTM1—kidney cancer	3.3e-06	4.88e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PTGS2—kidney cancer	3.3e-06	4.87e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CRABP1—kidney cancer	3.28e-06	4.85e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.25e-06	4.81e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—GSTP1—kidney cancer	3.21e-06	4.74e-05	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—PIK3CA—kidney cancer	3.15e-06	4.65e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—BCHE—kidney cancer	3.14e-06	4.64e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—GSTP1—kidney cancer	3.13e-06	4.63e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—CYP1A1—kidney cancer	3.13e-06	4.63e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—SLC5A5—kidney cancer	3.1e-06	4.58e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ITPR2—kidney cancer	3.05e-06	4.51e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—ABCB1—kidney cancer	3.04e-06	4.49e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—MAPK3—kidney cancer	3.03e-06	4.48e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—SLC2A1—kidney cancer	3e-06	4.43e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PTGS2—kidney cancer	2.97e-06	4.39e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PTEN—kidney cancer	2.97e-06	4.39e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.97e-06	4.38e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—MYC—kidney cancer	2.95e-06	4.36e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—GSTM1—kidney cancer	2.95e-06	4.36e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—GSTP1—kidney cancer	2.93e-06	4.32e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.91e-06	4.3e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—MAPK1—kidney cancer	2.89e-06	4.26e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—GSTM1—kidney cancer	2.88e-06	4.25e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PTEN—kidney cancer	2.88e-06	4.25e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.81e-06	4.15e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—CYP1A1—kidney cancer	2.79e-06	4.13e-05	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—PIK3CA—kidney cancer	2.79e-06	4.13e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GSTT1—kidney cancer	2.78e-06	4.11e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ACHE—kidney cancer	2.78e-06	4.11e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—ABCB1—kidney cancer	2.77e-06	4.09e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—POMC—kidney cancer	2.76e-06	4.07e-05	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—PIK3CA—kidney cancer	2.75e-06	4.07e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—CYP1A1—kidney cancer	2.73e-06	4.03e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—KRAS—kidney cancer	2.73e-06	4.03e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PTGS2—kidney cancer	2.73e-06	4.03e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—POMC—kidney cancer	2.7e-06	3.99e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—POMC—kidney cancer	2.7e-06	3.98e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—GSTM1—kidney cancer	2.69e-06	3.97e-05	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—PIK3CA—kidney cancer	2.68e-06	3.96e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—SCARB1—kidney cancer	2.63e-06	3.89e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PTGS1—kidney cancer	2.61e-06	3.85e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PTEN—kidney cancer	2.59e-06	3.83e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.57e-06	3.8e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PSMD7—kidney cancer	2.56e-06	3.78e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—CYP1A1—kidney cancer	2.55e-06	3.76e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—POMC—kidney cancer	2.55e-06	3.76e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.54e-06	3.75e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—PIK3CA—kidney cancer	2.5e-06	3.7e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—GSTP1—kidney cancer	2.5e-06	3.69e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—BCHE—kidney cancer	2.42e-06	3.58e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.39e-06	3.54e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PTEN—kidney cancer	2.38e-06	3.51e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—ABCB1—kidney cancer	2.37e-06	3.5e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—POMC—kidney cancer	2.33e-06	3.45e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.31e-06	3.42e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—GSTM1—kidney cancer	2.3e-06	3.39e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.3e-06	3.39e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PTGS2—kidney cancer	2.2e-06	3.25e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CYP1A1—kidney cancer	2.18e-06	3.22e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PTGS2—kidney cancer	2.15e-06	3.18e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PTGS2—kidney cancer	2.15e-06	3.18e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PIK3CA—kidney cancer	2.1e-06	3.1e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.09e-06	3.09e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—POMC—kidney cancer	2.08e-06	3.08e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—POMC—kidney cancer	2.03e-06	3e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PTGS2—kidney cancer	2.03e-06	3e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PIK3CA—kidney cancer	2.03e-06	3e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GSTP1—kidney cancer	1.93e-06	2.85e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PTEN—kidney cancer	1.92e-06	2.83e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—POMC—kidney cancer	1.9e-06	2.81e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PTEN—kidney cancer	1.88e-06	2.78e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PTEN—kidney cancer	1.87e-06	2.77e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PTGS2—kidney cancer	1.86e-06	2.75e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PIK3CA—kidney cancer	1.83e-06	2.7e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ABCB1—kidney cancer	1.83e-06	2.7e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.79e-06	2.64e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GSTM1—kidney cancer	1.77e-06	2.62e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PTEN—kidney cancer	1.77e-06	2.62e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.68e-06	2.48e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PIK3CA—kidney cancer	1.68e-06	2.48e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PTGS2—kidney cancer	1.66e-06	2.46e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PTEN—kidney cancer	1.62e-06	2.4e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—POMC—kidney cancer	1.62e-06	2.4e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PTGS2—kidney cancer	1.62e-06	2.4e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PTGS2—kidney cancer	1.52e-06	2.24e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PTEN—kidney cancer	1.45e-06	2.14e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PTEN—kidney cancer	1.41e-06	2.09e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PIK3CA—kidney cancer	1.35e-06	2e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PIK3CA—kidney cancer	1.33e-06	1.96e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.32e-06	1.95e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PTEN—kidney cancer	1.32e-06	1.95e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PTGS2—kidney cancer	1.29e-06	1.91e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—POMC—kidney cancer	1.25e-06	1.85e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PIK3CA—kidney cancer	1.25e-06	1.85e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.15e-06	1.69e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PTEN—kidney cancer	1.13e-06	1.67e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.02e-06	1.51e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PTGS2—kidney cancer	9.99e-07	1.48e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PIK3CA—kidney cancer	9.98e-07	1.47e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PIK3CA—kidney cancer	9.32e-07	1.38e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PTEN—kidney cancer	8.72e-07	1.29e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PIK3CA—kidney cancer	7.97e-07	1.18e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PIK3CA—kidney cancer	6.15e-07	9.08e-06	CbGpPWpGaD
